News

Hexoskin is attending this week the Québec Respiratory Health Congress in Montréal.

Hexoskin is attending this week the Québec Respiratory Health Annual Congress (Congrès Québécois en Santé Respiratoire) of the Quebec Lung Association, on October 24 & 25, 2019 at the Montréal Science Center.

The Hexoskin team will meet with specialists, researchers and many stakeholders in Respiratory and Pulmonary Health. Our team will present its Connected Health Platform and its expertise for remote monitoring of patients with respiratory diseases from the comfort of their homes.

At Hexoskin, we're committed to work with organizations like the Québec Lung Association (APQ), American College of Chest Physicians, American Thoracic Society (ATS), COPD Foundation, the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), the American Heart Association (AHA), the Alliance for Artificial Intelligence in Healthcare (AAIH) and many others to develop new standards of care for these chronic patients.

If you're a Pharma, a Medical company or a Healthcare provider interested in patient remote monitoring with digital markers, sensors, and AI, please contact us.

About Hexoskin
Founded in 2006 in Montreal, Hexoskin (Carré Technologies) is involved in the development of non-invasive sensors, software and applications, data science services and AI. Hexoskin's mission is to record and categorize personal health information, to make it accessible and useful.

Hexoskin takes part in the AAIH reflection about Artificial Intelligence in Healthcare

The Alliance for Artificial Intelligence in Healthcare (AAIH) just published a white paper titled "A Primer on AI in Healthcare".

The Primer on AI in Healthcare attempts to cover many uses for AI in healthcare in a way that is accessible, but also as precise and concrete as possible. We hope this document will serve as a reference for future discussions and publications for all stakeholders in healthcare and AI, including patients and providers.

A Primer on Artificial Intelligence in Healthcare - A technical introduction
The 45-page document describes AI approaches and applications in healthcare and biopharma research, and helps introduce standard definitions for the industry.

The Hexoskin Team is proud to have taken part in this reflection that will drive the future of AI development for Connected Health in healthcare.

"It was important for me to contribute to this essential white paper. There was a need to clarify terms and concepts in AI with an emphasis on applications in healthcare, biomedical discovery, clinical development, and home care". Pierre-Alexandre-Fournier - CEO at Hexoskin.

Hexoskin is Attending Chest Annual Meeting in New Orleans On October 19-23, 2019.

Hexoskin is attending the Chest Annual Meeting on October 19-23, 2019 in New Orleans.

The Hexoskin Team will be meeting with Chest Physicians and multiple stakeholders from Lung Health and Clinical Chest Medicine. Our team will showcase its Connected Health Platform and expertise for monitoring patients with chronic respiratory & cardiac diseases remotely, from the comfort of their home.

If your company is interested in digital markers, sensors and AI in healthcare, book a meeting with our team y contacting us.

Introducing the New Hexoskin ProShirt

Hexoskin is launching the new ProShirt line for Men and Women with an all-new design to withstand the most active lifestyle and diverse daily living activities. The Hexoskin ProShirt comes with built-in textile ECG & Respiratory sensors and a precise Activity sensor.

New Features for Improved Data Collection and Comfort:

Inspired by our most advanced users, the new Hexoskin ProShirt delivers a host of new features with 20 upgrades & improvements compared to our standard Hexoskin Smart Clothing product line.

Today, the Hexoskin ProShirts are used by professional athletes for performance training, police & first responders for longitudinal stress monitoring, and patients in clinical trials living with chronic cardiac & respiratory conditions.

Key Improvements of the Hexoskin ProShirt for Men & Women Include:

• Enhanced form factor for a more comfortable fit for active & sleep activities
• New adjustable elastic belts incorporated into the Hexoskin ProShirt
• New Dual-Pocket for the Hexoskin Smart recording device to adapt to a wide range of activities and sleeping positions
• Designed to withstand tough conditions.

All-New Design for Women:

• Incorporated shoulder strap adjusters to ensure a comfortable fit
• Breathable mesh panels that wick away sweat
• Built-in bra includes pockets for optimal comfort with removable cups.

Hexoskin ProShirt Specifications:

• Machine washable (piling and stretching resistant)
• Lightweight & quick to dry
• Fit optimized for regulation of moisture/heat
• 99.9% antibacterial treatment (no odors)
• Excellent UV Protection
• 73% Polyamide Micro/27% Elastane.

Meet Hexoskin at the 34th American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) Annual Meeting in Portland (OR) on September 18-21!

Hexoskin has been working for many years with rehabilitation professionals to provide more insights about patients recovering at home. The 34th American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) Annual Meeting in Portland (OR) on September 18-21 will be another great opportunity to connect with the experts who make rehabilitation easier for patients!

AACVRP is home for Cardiovascular and Pulmonary Rehabilitation professionals, where they discuss and promote experiences, challenges, advances and research. We are looking forward to working with a diverse group of heart, respiratory and rehabilitation care specialists to explore new paths to deliver cutting-edge science that keeps patients in the comfort of their home.

The Hexoskin Team will be hosting meetings at the Oregon Convention Center in Portland, Oregon. Our team will be presenting demos of its new clinically validated collection of Smart Garments for remote patient monitoring along with the Hexoskin Connected Health Platform, already used for rehabilitation and health research in cardiology, pulmonology, psychiatry, rare diseases and many other health conditions.

Keep patients at home. Make patients healthier. That's what professionals working in cardiac rehabilitation and pulmonary rehabilitation do. All year long. Hexoskin helps them get data about their patients and answer these questions: 

• how active are my patients?
• how do their heart/lungs respond to exercise?
• how compliant are they to their exercise program?

This helps rehabilitation professionals personalize their approach and provide services to patients remotely. Almost every patient should be in a cardiac rehab program after a heart attack. Currently, in the US and Canada, less than 20% of eligible patients participate in a cardiac rehab program. For pulmonary rehab (COPD patients), it's less than 4%! This low participation rate is costing Medicare billions of dollars in additional hospitalization fees. Most importantly, millions of patients are not getting the care that would keep them out of the hospital. We need to make cardiac and pulmonary rehabilitation more accessible. That's why we'll be in Portland this week.

About Hexoskin
Founded in 2006 in Montreal, Hexoskin (Carré Technologies Inc.) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.

Hexoskin presents its data-driven model for algorithms development and AI services at Intelligent Health 2019, in Basel

On September 12th this week, Hexoskin's Co-founder & CTO Jean-François Roy will discuss sensors, data, and AI in medicine at the Intelligent Health AI conference in Basel, Switzerland.

Hexoskin has been chosen among only 5 companies in the world to present at the Showcase event at the conference sponsored by Novartis. Hexoskin's Chief Technology Officer Jean-François Roy will present new opportunities for healthcare and pharmaceutical organizations to uncover new insights from the data they have collected from clinical trials.

Artificial Intelligence and Machine Learning have the potential to transform drug development and reduce the time to market of much-needed therapies in various therapeutic areas, including rare diseases, and find new cures for millions of patients.

The Hexoskin end-to-end data platform is secure and platform agnostic. Hexoskin's clients have access to cost-effective tools to manage clinical studies, collect rich health data, and build unique databases and datasets for machine learning & AI projects.

Hexoskin has a dedicated group of AI & biomedical researchers with years of experience in preparing and analyzing health data, and in the development of machine learning algorithms with health data. Its research team collects new vital signs data and use external datasets to answer novel research questions.

“Hexoskin was founded in 2006 to develop sensors and information systems to support Artificial Intelligence applications for clinical research and healthcare”.

• Jean-François Roy is CTO and co-founder of Hexoskin (Carré Technologies Inc.). Since 2006 he leads the R&D company development to develop wearable biosensors and mobile applications.  He is a specialist in embedded systems, an experienced ASIC, FPGA and board designer. He also developed signal processing algorithms in many programming languages. He’s been involved with the design, development, integration, and testing of the Hexoskin/Astroskin system and related biomedical technologies since 2006.

 About Hexoskin:

Founded in 2006 in Montreal, Hexoskin is the leader in non-invasive sensors, smart clothing, software, data science & AI services. Hexoskin launched in 2013 the first washable smart shirts that capture cardiac, respiratory, and activity body metrics. The Hexoskin platform is an end-to-end software system to monitor and analyse users' general health, vital signs, sleep, and activity, using built-in sensors embedded in smart garments made in Canada.

The Hexoskin smart clothing and Hexoskin Connected Health Platform has been used to collect data for over 70 scientific publications in the fields of cardiology, respiratory, behavioural & physiological psychology, sleep patterns, circadian rhythms, effects of aging on physical performance, and AI-Machine Learning. The company provides custom solutions, R&D project management, and services to international clients including pharmaceuticals, research centers, government agencies, and healthcare providers.

Meet Hexoskin at DSEI in London on September 10-13, 2019

Hexoskin is attending the DSEI Defense & Security convention on September 10-13, 2019 in London.

Our team will be hosting meetings in London with Defense & Security stakeholders to showcase our solutions and expertise for monitoring soldiers & first responders vital signs, health status, stress, and performance in training or in the field. 

DSEI is the world-leading event that connects governments, national armed forces, industry thought leaders in the global defense, first response, & security supply. Where to showcase the latest equipment and systems available and discover our latest capabilities across the Defense & Security domains. 

The Hexoskin Team will be introducing the next evolution of smart clothing for defense, first responders, and stress monitoring: the Hexoskin ProShirt.

Pre-orders are available now and will start shipping on September 10, 2019.

To learn more about the Hexoskin Connected Health Platform and solutions for First Responders & Defense, book a meeting with our team!

Hexoskin and Halo Health to solve key challenges of clinical trials.

Hexoskin and Halo Health are announcing today a collaboration to solve key challenges in running clinical trials. Combining Hexoskin and Halo Health's technology will offer greater operational efficiency for virtual clinical trials and home monitoring, and offer tools to increase patient engagement.

These new tools will reduce the cost of collecting vital signs data for clinical trials, and will allow patients to participate in medical research from the comfort of their home.

Hexoskin smart garments and its Connected Health Platform are compatible with Halo Health solutions. The two companies will mutually promote their offering to pharmaceutical sponsors to support clinical development.

Halo Health is enabling patient-centric trials to reduce patient and site burden. Its Smart Clinical Trials solution is a digital health platform that provides Remote Patient Monitoring, Patient Engagement, and Workflow Automation. The solution includes an integrated ecosystem of clinical grade sensors and wearables to enable hybrid & virtual trials for various therapeutic areas including cardiology, respiratory and endocrinology.

Pierre-Alexandre Fournier - Chief Executive Officer at Hexoskin: “Medicine's progress depends on being able to better observe patients' outcomes. Anything we can do to lower the cost of data helps accelerate clinical development. This is something that Pharma and Biotech companies need to innovate, but most importantly this is something that we need to do to improve treatments for patients and find new cures for diseases that affect millions of people and their families.” says Pierre-Alexandre Fournier, Chief Executive Officer at Hexoskin. “Combining Halo Health's software with Hexoskin sensors and algorithms reduces the cost of collecting data in clinical trials, with greater flexibility & patient centricity.”

Hexoskin is a pioneer and leader in non-invasive vital signs sensors and remote patient monitoring solutions. Hexoskin Smart Clothing for Men, Women, and Children are clinically validated and its Connected Health Platform is used for health research in cardiology, pulmonology, psychiatry, rare diseases and many other health conditions.

We’re attending #DPHARM2019 in #Boston, at HaloHealth's Kiosk on September 17 & 18, 2019! Visit Booth 30 to learn about our joint innovative solutions to solve the key challenges of Clinical-trials! 

Contact Hexoskin to learn more.

Advancing space medicine knowledge aboard the ISS. Another space mission for Astroskin / Bio-Monitor!

Earlier this month, European Space Agency astronaut Luca Parmitano conducted validation tests on-orbit and wore the Astroskin garment and headband connected to the data unit for his first 72-hour monitoring experience.

Luca Parmitano also conducted maintenance operations for the Astroskin / Bio-Monitor that was deployed on the ISS orbiting lab, last December by Canadian Astronaut David Saint-Jacques.

Although the ISS is equipped with health and life sciences research tools, the existing instrumentation for continuous and simultaneous recording of several physiological parameters was lacking. To address this issue, the Canadian Space Agency's Bio-Monitor Commissioning activity uses the Astroskin / Bio-Monitor system; a complete vital signs monitoring platform coupled with a wearable garment capable of monitoring relevant physiological parameters in a non-invasive and non-interfering way during a normal day in space. 

The physiological parameters which can be monitored consist of blood pressure, peripheral blood oxygen saturation, 3-lead ECG, respiration, skin temperature, and activity, will help push further our understanding of Vascular aging and Human Physiology in space. 

Venturing into the environment of space, microgravity can have negative effects on the human body. When astronauts return to Earth, their carotid arteries, which carry blood to the head and neck, appear to have aged 20 to 30 years. Artery walls become stiffer and thicker in space, the same as when people grow older on Earth.

“You can take extremely healthy, fit astronauts and put them in an environment that restricts their ability to do daily exercise, and they run the risk of developing insulin resistance that on Earth could lead to Type II diabetes,” said principal investigator Richard L. Hughson of Schlegel-University of Waterloo in Ontario

Now operational the Astroskin Bio-Monitor system is available for the next five years to conduct Health research in Space for all participating countries to the International Space Station.

Sometimes you wear the experiment: the Bio-Monitor smart shirt system measures vital signs like temperature, heart rate, respiration and movement, and transmits the data to a tablet application. #MissionBeyond @csa_asc pic.twitter.com/2h6lmRUyHH

— Luca Parmitano (@astro_luca) 19 août 2019

Source:
NASA. 2019. ISS Daily Summary Report - 8/14/2019
NASA. 2019. ISS Daily Summary Report - 8/13/2019

About Hexoskin
Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. The Astroskin demonstrates once again Hexoskin’s leadership in providing the industry leading sensors, software, and AI to push further our understanding of human physiology on earth and in space.

Hexoskin to build world’s largest database of vital signs for Myalgic Encephalomyelitis patients with ICANCME Research Network

Montreal, Canada, August 22, 2019  - The CIHR (Canadian Institutes of Health Research) organized a press conference at CHU Sainte-Justine, Mother and Child University Hospital Center today to announce the funding of a five-year project to collect biological and vital signs data from patients suffering from Myalgic Encephalomyelitis (ME), also known as Chronic Fatigue Syndrome (CFS), to improve medical knowledge of the disease. Canadian Minister of Health, the Honourable Ginette Petitpas Taylor, was at the event to make the announcement with Dr. Alain Moreau, Scientific Director of the Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases.

In Canada, over half a million Canadians suffer from ME. According to the CDC (Center for Disease Control and Prevention), in the United States, 836,000 to 2.5 million Americans suffer from ME, but most of them have not been diagnosed. There is currently no biological diagnostic test for ME. The disease is diagnosed based on symptoms and by ruling out other conditions that could be causing the symptoms. The CHIR funded project will build the largest long-term cardiopulmonary and activity database in the world for patients with ME.

Hexoskin, a Montreal-based leader in smart clothing, health software, and AI services will provide its health monitoring solutions to support building the database. Pierre-Alexandre Fournier, CEO of Hexoskin, is pleased by today’s announcement: ‘’We believe this project will help us understand how to better take care of patients presenting symptoms of ME. Recent data shows that the prevalence of this disease is higher than previously estimated and has an enormous impact on Canadians living with ME and our society. Data collected in this project will impact millions of lives’’.

Dr. Alain Moreau will be the Principal Investigator with the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis - ICANCME - Research Network: “Myalgic Encephalomyelitis (ME) is possibly the last medical enigma of the 21st century. Our scientific partnership with Hexoskin will be instrumental to address the complexity of ME given its clinical heterogeneity and phenotypic variability overtime. The Hexoskin wearable technologies will allow researchers and clinicians to investigate people severely affected by ME (housebound or bedridden), which is rarely done due to their limited capacity to participate in clinical studies.”

Learn more on Health Research with Hexoskin.
To order, visit the Hexoskin Online Store or contact sales@hexoskin.com.

About Hexoskin:
Founded in 2006 in Montreal, Hexoskin is the leader in non-invasive sensors, smart clothing, software, data science & AI services. Hexoskin launched in 2013 the first washable smart shirts that capture cardiac, respiratory, and activity body metrics. Hexoskin is an end-to-end system to monitor the user’s general health, vital signs, sleep, and activity, using built-in sensors embedded in Smart Garments made in Canada. The system can be used for a wide range of research domains including cardiology, respiratory, behavioural and physiological psychology, biofeedback, sleep patterns, circadian rhythms, effects of aging on physical performance, human energy expenditure, and physical conditioning.

The Hexoskin smart clothing and solutions were validated in over 70 scientific publications in the fields of cardiology, respiratory, behavioural and physiological psychology, sleep patterns, circadian rhythms, effects of aging on physical performance, and AI-Machine Learning. The company provides custom solutions, R&D project management, and services to international clients in defence, aerospace, security, police and first responders, pharmaceuticals, academics, and healthcare.

Hexoskin is also known for collaborating with the Canadian Space Agency to provide its advanced health technologies Astroskin (Bio-Monitor) to monitor the vital signs of the Canadian Astronaut David Saint-Jacques and future astronauts visiting in the International Space Station for the next five years. The company launched in 2018 the Astroskin platform for research and public/private projects on Earth.